Faculty profile

Sasha Bernatsky

ResearcherMedicineMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Sasha Bernatsky

Researcher

Medicine

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
114 publications in the last five years, latest in 2026.
Senior (last) author on 36 recent papers, a sign of leading a research group.
Principal investigator on 32 research grants (32 CIHR), most recently in 2026.
Supervised 7 trainees who won CIHR awards, most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

342

Publications

991

Citations

h-index

193

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Rheumatoid Arthritis Epidemiology Health Outcomes Systemic Lupus Erythematosus Drug Safety Rheumatology Air Pollution Drug Effectiveness

Latest papers

Reply.
Arthritis & rheumatology (Hoboken, N.J.) · 2026 · first author
Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.
Journal of clinical epidemiology · 2026
Recent hydromorphone injection and risk of incident infective endocarditis among people who inject drugs in Toronto, Canada: a cohort study.
Harm reduction journal · 2026

All 342 publications

Latest funding

Personalizing Therapy to Optimize Outcomes by Synthesizing Real-World Evidence and Establishing Patient Preferences
CIHR · 2026 · Nominated PI
$443,700
Dose of Induction Methylprednisolone in Severe ANCA-Associated Vasculitis (DIMeS-AAV)
CIHR · 2025 · Co-investigator
$86,875
New statistical methods for assessing cumulative effects of past and recent values of time-varying risk and prognostic factors: development, validation and real-world epidemiological and clinical applications
CIHR · 2025 · Co-investigator
$742,052

All 53 grants and awards

From the 150 most recent of 342 publications.

Reply.

Bernatsky S, Zhao N

Arthritis & rheumatology (Hoboken, N.J.)2026First author

DOI: 10.1002/art.43378 PMID: 40931875

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.

Kaddoura R, Bernatsky S, Beauchamp ME, Guerra SF, Almeida-Brasil CC, Hanly JG, Urowitz M, Clarke AE, Ruiz-Irastorza G, Gordon C, Ramsey-Goldman R, Petri MA, Ginzler EM, Wallace DJ, Bae SC, Romero-Diaz J, Dooley MA, Peschken C, Isenberg D, Manzi S, Jacobsen S, Lim SS, Nived O, Jönsen A, Kamen DL, Aranow C, Sánchez-Guerrero J, Gladman DD, Fortin PR, Alarcón GS, Merrill JT, Kalunian K, Ramos-Casals M, Zoma AA, Askanase AD, Khamashta M, Bruce IN, Inanc M, Lukusa L, Abrahamowicz M

Journal of clinical epidemiology2026

DOI: 10.1016/j.jclinepi.2026.112261 PMID: 41921830

Recent hydromorphone injection and risk of incident infective endocarditis among people who inject drugs in Toronto, Canada: a cohort study.

Bakewell N, Bouck Z, Greenwald ZR, Upham K, Warren CM, Birck MG, Moura CS, Bernatsky S, Neville A, Gomes T, Werb D

Harm reduction journal2026

DOI: 10.1186/s12954-026-01479-x PMID: 42321840

Fine Particulate Matter Constituents, Ozone, and Systemic Lupus Erythematosus: A Large General-Population Cohort Analysis With Extended Quantile g-Computation.

Zhao N, Bernatsky S, Dowell S, Banbury B, Curtis JR, Wright GC, Holladay EE, Mudano A, Moura CS, Kerr GS

Arthritis & rheumatology (Hoboken, N.J.)2026

DOI: 10.1002/art.70234 PMID: 42233343

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

Arnaud L, Monticielo OA, Piga M, Costedoat-Chalumeau N, Touma Z, Ruiz-Irastorza G, Bae SC, Bernatsky S, Bonfa E, Bottazzi F, Cervera R, Chehab G, Clarke AE, Dall'era M, Duarte-Garcia A, Espinosa G, Fortin PR, Fredi M, Gómez-Puerta JA, Izuka S, Jönsen A, Khmelinskii N, Legge A, Meisalu S, Moroni L, Orsolini G, Padjen I, Petri M, Pons-Estel G, Ramirez GA, Ramsey-Goldman R, Sciascia S, Tincani A, Triggiani M, Ugarte-Gil MF, Vinet E, Vital EM, Mosca M, Tani C, ERN ReCONNET–SLICC–SLEuro rare SLE taskforce member panel

The Lancet. Rheumatology2026

DOI: 10.1016/s2665-9913(26)00141-4 PMID: 42648304

A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.

Aly S, Parastandehchehr G, Bernatsky S, Vinet É, Arnaud L, Costedoat-Chalumeau N, Fortin PR, Reynolds JA, Thorne JC, Touma Z, Wallace D, Werth VP, Singer W, Mendel A

The Journal of rheumatology2026

DOI: 10.3899/jrheum.2025-0757 PMID: 41326167

Ambient PM2.5 Exposure and the Incidence of Systemic Lupus Erythematosus: A Review.

Moghaddam SM, Zhao N, Bernatsky S

Rheumatic diseases clinics of North America2026Senior author

DOI: 10.1016/j.rdc.2025.08.004 PMID: 41265947

Immunogenicity of COVID-19 booster vaccines in children receiving immunosuppressive medications.

Shapiro JR, Choi F, Xu A, Duong TT, Gingras AC, Colwill K, Bernatsky S, Benseler SM, Yeung RS, SUCCEED KIDS Team

Pediatric research2026

DOI: 10.1038/s41390-025-04174-y PMID: 40691289

Patient perspectives on clinical trial participation for novel advanced therapies: a focus group study in systemic lupus erythematosus.

Stein OA, Lee JLF, Vinet E, Mendel A, Pineau CA, Kalache F, Grenier LP, Mielczarek L, Bernatsky S

Rheumatology international2026Senior author

DOI: 10.1007/s00296-026-06071-x PMID: 41571944

Fine particulate matter air pollution and anti-nuclear antibodies.

Zhao N, Smargiassi A, Chen H, Choi MY, Fritzler MJ, Touma Z, Aviña-Zubieta JA, Bernatsky S

Rheumatology (Oxford, England)2026Senior author

DOI: 10.1093/rheumatology/keaf545 PMID: 41131821

Personalizing Therapy to Optimize Outcomes by Synthesizing Real-World Evidence and Establishing Patient Preferences

Nominated PICIHR2026Project Grant

Principal investigators: Bernatsky, Sasha R; Hazlewood, Glen S

Keywords: Drug Effectiveness; Drug Safety; Health Outcomes Research; Patient Preferences; Rheumatology; Systemic Lupus

$443,700

Dose of Induction Methylprednisolone in Severe ANCA-Associated Vasculitis (DIMeS-AAV)

Co-investigatorCIHR2025Project Grant

Principal investigators: Mendel, Arielle; Walsh, Michael W

Keywords: Anca-Associated Vasculitis; Anti-Neutrophil Cytoplasm Antibody; Drug Safety And Effectiveness; End-Stage Kidney Disease; Glomerulonephritis; Glucocorticoids; Methylprednisolone; Prospective Study; Serious Infections

$86,875

New statistical methods for assessing cumulative effects of past and recent values of time-varying risk and prognostic factors: development, validation and real-world epidemiological and clinical applications

Co-investigatorCIHR2025Project Grant

Principal investigators: Abrahamowicz, Michal M

Keywords: Biostatistics; Cardiovascular And Cancer Epidemiology; Cohort Studies; Cumulative Effects; Model Development And Validation; Non-Linear Effects; Simulations; Sparse Longitudinal Data; Survival Analysis; Time-Varying Risk/Prognostic Factors

$742,052

Environmental factors and risk of autoimmune rheumatic disease incidence and serology

Nominated PICIHR2024Project Grant

Principal investigators: Bernatsky, Sasha R; Avina-Zubieta, Juan A; Chen, Hong; Smargiassi, Audrey

Keywords: Air Pollution; Autoimmune Rheumatic Disease; Climate Change; Environment; Epidemiology; Health Outcomes; Humidity; Immunity; Musculoskeletal Diseases; Rheumatoid Arthritis

$502,990

Immunogenicity and safety of COVID-19 vaccine Co-administration and Interval in Immunocompromised hosts (CO2I2 Trial).

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects

Principal investigators: Sapir-Pichhadze, Ruth; Stalker, Leanne; Colmegna, Ines; Costiniuk, Cecilia T; Suri, Rita

Keywords: Cellular Immunity; Cost Effectiveness; Covid-19; Humoral Immunity; Immunogenicity; Influenza; Neutralization; Quality Of Life; Safety; Vaccine

$5,222,039

Environmental factors and risk of autoimmune rheumatic disease incidence and serology

Nominated PICIHR2023Project Grant - Priority Announcement: Health and Climate Change

Principal investigators: Bernatsky, Sasha R; Avina-Zubieta, Juan A; Chen, Hong; Smargiassi, Audrey

Keywords: Air Pollution; Autoimmune Rheumatic Disease; Climate Change; Environment; Epidemiology; Health Outcomes; Humidity; Immunity; Musculoskeletal Diseases; Rheumatoid Arthritis

Immunogenicity and safety of COVID-19 vaccine Co-administration and Interval in Immunocompromised hosts (CO2I2 Trial).

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Sapir-Pichhadze, Ruth; Stalker, Leanne; Colmegna, Ines; Costiniuk, Cecilia T; Suri, Rita

Keywords: Cellular Immunity; Cost Effectiveness; Covid-19; Humoral Immunity; Immunogenicity; Influenza; Neutralization; Quality Of Life; Safety; Vaccine

$1,305,510

Risk stratification and personalized therapy in lupus pregnancies

Co-investigatorCIHR2022Project Grant

Principal investigators: Vinet, Evelyne

Keywords: Adverse Pregnancy Outcomes; Antiphosphatidylserine/Prothrombin Antibodies (Aps/Pt); Antiphospholipid Antibodies; Disease Flare; Lupus Low Disease Activity State (Lldas); Placenta-Mediated Complications; Pregnancy; Risk Factors; Systemic Lupus Erythematosus; Therapeutic Drug Monitoring

$757,350

AI & Personalized Therapeutics

Co-investigatorCIHR2022Project Grant

Principal investigators: Tamblyn, Robyn M; Filion, Kristian B; McDonald, Emily G; Singer, Wendy

Keywords: Artificial Intelligence; Big Data; Machine Learning; Patient-Reported Outcomes; Personalized Medicine; Pharmacare; Pragmatic Trials; Predictive Analytics; Reinforcement Learning

$910,350

New statistical methods for population-based studies of time-varying drug exposures: development, validation, and real-world analyses of drug safety and effectiveness

Co-investigatorCIHR2021Project Grant

Principal investigators: Abrahamowicz, Michal M

Keywords: Absolute Risks; Biostatistics; Cumulative Effects; Drug Safety And Effectiveness; Exposure Measurement Errors; New Methods; Pharmacoepidemiology; Simulations; Time-Varying Exposures; Unmeasured Confounding

$481,950

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Sasha Bernatsky

Research

Latest papers

Latest funding

Reply.

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.

Recent hydromorphone injection and risk of incident infective endocarditis among people who inject drugs in Toronto, Canada: a cohort study.

Fine Particulate Matter Constituents, Ozone, and Systemic Lupus Erythematosus: A Large General-Population Cohort Analysis With Extended Quantile g-Computation.

ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).

A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.

Ambient PM2.5 Exposure and the Incidence of Systemic Lupus Erythematosus: A Review.

Immunogenicity of COVID-19 booster vaccines in children receiving immunosuppressive medications.

Patient perspectives on clinical trial participation for novel advanced therapies: a focus group study in systemic lupus erythematosus.

Fine particulate matter air pollution and anti-nuclear antibodies.

Frequent collaborators

Sasha Bernatsky

Marie Hudson

Evelyne Vinet

Evelyne Vinet

Michal Abrahamowicz

Jessica Widdifield

Christine Peschken

Arielle Mendel

Arielle Mendel

Murray Baron

Lawrence Joseph

Ines Colmegna

Murray Urowitz

Elham Rahme

J Michael Paterson

Louise Pilote

Lihi Eder

Sasha Bernatsky

Paul Fortin

Jessica Widdifield

Louise Pilote

Margaret Larche

Carol Hitchon

Karen Tu

Nader Khalidi

Claire Bombardier

Ann Clarke

John Hanly

Dawn Bowdish

Anne-Claude Gingras

Deborah Da Costa

Louis Flamand

Brenda Hemmelgarn

Neeraj Narula

Derek Allan Haaland

Helen Tremlett

Raj Carmona

Mark Matsos

Viktoria Pavlova

Raja Bobba